Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-09-21

Clinical Trial Update: The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating local tranexamic acid in periorbital oculoplastic surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Miami | Conditions: Eyelid Diseases, Periorbital Disorder | Phase 4 | Status: WITHDRAWN